MarketGrader Ratings Overview
MarketGrader China A-Shares Health Care 30 Index
Five Largest Companies (Top 5 of 19)
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 600276.CN | Jiangsu Hengrui Medicine Co., Ltd. Class A | 66.7 | $71,949.76 | CN |
| 000661.CN | Changchun High & New Technology Industry (Group) Inc. Class A | 81.4 | $22,529.95 | CN |
| 600436.CN | Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A | 56.8 | $22,164.52 | CN |
| 000538.CN | Yunnan Baiyao Group Co. Ltd. Class A | 56.2 | $19,862.08 | CN |
| 300347.CN | Hangzhou Tigermed Consulting Co., Ltd. Class A | 62.1 | $13,108.81 | CN |
Five Smallest Companies (Top 5 of 11)
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300452.CN | Anhui Sunhere Pharmaceutical Excipients Co., Ltd. Class A | 57.4 | $562.55 | CN |
| 603309.CN | WELL LEAD MEDICAL CO LTD Class A | 82.0 | $589.06 | CN |
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 68.5 | $718.25 | CN |
| 300246.CN | Guangdong Biolight Meditech Co., Ltd. Class A | 87.9 | $788.54 | CN |
| 600557.CN | Jiangsu Kanion Pharmaceutical Co. Ltd. Class A | 48.1 | $1,113.46 | CN |
Companies with Most Selections Among Current Components
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 600276.CN | Jiangsu Hengrui Medicine Co., Ltd. Class | 66.7 | 21 | CN |
| 000538.CN | Yunnan Baiyao Group Co. Ltd. Class A | 56.2 | 17 | CN |
| 600436.CN | Zhangzhou Pientzehuang Pharmaceutical Co | 56.8 | 15 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 74.0 | 14 | CN |
| 000661.CN | Changchun High & New Technology Industry | 81.4 | 13 | CN |
| 600566.CN | HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Cl | 55.6 | 11 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 64.5 | 9 | CN |
| 002019.CN | Yifan Pharmaceutical Co., Ltd. Class A | 68.6 | 8 | CN |
| 600557.CN | Jiangsu Kanion Pharmaceutical Co. Ltd. C | 48.1 | 8 | CN |
| 600750.CN | Jiangzhong Pharmaceutical Co., Ltd. Clas | 64.7 | 7 | CN |
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
| Average Market Cap | $7,637.24 |
| Median Market Cap | $2,801.19 |
| Avg. 3 Mo. Dollar Vol. | $79,301,255.43 |
| Avg. 3 Mo. Trading Vol. | 11,591,857 |
| Last Rebalance Date | 06/15/2020 |
| Companies Replaced | 16 |
| Biggest Industry Increase | Health Care |
| Biggest Industry Decrease | Health Care |
Fundamental Attributes
| Trailing P/E Ratio (12 Mo.) | 32.21 |
| Forward P/E Ratio (12 Mo.) | 29.66 |
| Price/Book Ratio | 4.68 |
| Avg. Revenue Chg. - 3 Yr | 81.99% |
| Avg. Op. Income Chg. - 3 Yr. | 92.97% |
| Avg. EPS Growth - 3 Yr. | 21.82% |
| Avg. EPS Growth - 1 Yr. | 22.69% |
| Avg. Operating Margin | 22.47% |
| Avg. LT Debt to Total Capital | 12.69% |
| Avg. Return on Equity | 19.07% |
| Dividend Yield | 0.72% |
Index Average Grade
| MarketGrader China A-Shares Health Care 30 Index | 66.67 |
Country Breakdown
| China | 100.0% |
For more information on this index please contact us